HR-positiver, HER2-negativer Brustkrebs: Real-World-Analyse zu CDK4/6-Inhibitoren
Crossref DOI link: https://doi.org/10.1007/s15013-025-6181-1
Published Online: 2025-09-08
Published Print: 2025-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2025-09-01
Version of Record valid from 2025-09-01
Article History
First Online: 8 September 2025
Free to read: This content has been made available to all.